These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 24467393)

  • 21. Health-related quality of life in patients with metastatic, relapsed, or inoperable squamous cell carcinoma of the head and neck in India.
    Noronha V; Joshi A; Marfatia S; Patil V; Juvekar S; Arya S; Banavali S; Prabhash K
    Support Care Cancer; 2016 Apr; 24(4):1595-602. PubMed ID: 26386707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation.
    Antunes HS; Herchenhorn D; Small IA; Araújo CM; Viégas CM; Cabral E; Rampini MP; Rodrigues PC; Silva TG; Ferreira EM; Dias FL; Ferreira CG
    Radiother Oncol; 2013 Nov; 109(2):297-302. PubMed ID: 24044799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Older Adult With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: Knowledge Gaps and Future Direction in Assessment and Treatment.
    Maggiore R; Zumsteg ZS; BrintzenhofeSzoc K; Trevino KM; Gajra A; Korc-Grodzicki B; Epstein JB; Bond SM; Parker I; Kish JA; Murphy BA; VanderWalde NA;
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):868-883. PubMed ID: 28602414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretreatment depression as a prognostic indicator of survival and nutritional status in patients with head and neck cancer.
    Kim SA; Roh JL; Lee SA; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
    Cancer; 2016 Jan; 122(1):131-40. PubMed ID: 26371775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Independence and health related quality of life in 200 onco-geriatric surgical patients within 6 months of follow-up: Who is at risk to lose?
    Baier P; Ihorst G; Wolff-Vorbeck G; Hüll M; Hopt U; Deschler B
    Eur J Surg Oncol; 2016 Dec; 42(12):1890-1897. PubMed ID: 27519617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting fatigue in older breast cancer patients receiving radiotherapy. A head-to-head comparison of established assessments.
    Denkinger MD; Hasch M; Gerstmayer A; Kreienberg R; Nikolaus T; Hancke K
    Z Gerontol Geriatr; 2015 Feb; 48(2):128-34. PubMed ID: 25592175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of clinical parameters predictive of one-year survival using two geriatric tools in clinically fit older patients with hematological malignancies: Major impact of cognition.
    Dubruille S; Libert Y; Roos M; Vandenbossche S; Collard A; Meuleman N; Maerevoet M; Etienne AM; Reynaert C; Razavi D; Bron D
    J Geriatr Oncol; 2015 Sep; 6(5):362-9. PubMed ID: 26277114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13.
    Luciani A; Ascione G; Bertuzzi C; Marussi D; Codecà C; Di Maria G; Caldiera SE; Floriani I; Zonato S; Ferrari D; Foa P
    J Clin Oncol; 2010 Apr; 28(12):2046-50. PubMed ID: 20308657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Head and neck specific Health Related Quality of Life scores predict subsequent survival in successfully treated head and neck cancer patients: a prospective cohort study.
    Osthus AA; Aarstad AK; Olofsson J; Aarstad HJ
    Oral Oncol; 2011 Oct; 47(10):974-9. PubMed ID: 21856209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of life, HPV-status and phase angle predict survival in head and neck cancer patients under (chemo)radiotherapy undergoing nutritional intervention: Results from the prospective randomized HEADNUT-trial.
    Kutz LM; Abel J; Schweizer D; Tribius S; Krüll A; Petersen C; Löser A
    Radiother Oncol; 2022 Jan; 166():145-153. PubMed ID: 34838889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. G8 and VES-13 as screening tools for geriatric assessment and predictors of survival in older Indian patients with cancer.
    Shah M; Noronha V; Ramaswamy A; Gattani S; Mokal S; Joshi A; Patil V; Menon N; Banavali S; Badwe R; Prabhash K
    J Geriatr Oncol; 2022 Jun; 13(5):720-730. PubMed ID: 35283049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility and tolerance of sequential chemoradiotherapy in squamous cell carcinoma of the head and neck.
    Loo SW; Geropantas K; Tasigiannopoulos Z; Martin C; Roques TW
    Eur J Cancer Care (Engl); 2013 Jan; 22(1):32-40. PubMed ID: 22519981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in the 15D health-related quality of life over the first year following diagnosis of head and neck cancer.
    Aro K; Bäck L; Loimu V; Saarilahti K; Rogers S; Sintonen H; Roine R; Mäkitie A
    Eur Arch Otorhinolaryngol; 2016 Aug; 273(8):2141-50. PubMed ID: 26216625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment approaches in elderly patients with head and neck cancer.
    Perri F; Ionna F; Pavone E; Longo F; Caponigro F
    Anticancer Agents Med Chem; 2013 Nov; 13(9):1383-90. PubMed ID: 24168150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study.
    Rathod S; Gupta T; Ghosh-Laskar S; Murthy V; Budrukkar A; Agarwal J
    Oral Oncol; 2013 Jun; 49(6):634-42. PubMed ID: 23562564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor site and disease stage as predictors of quality of life in head and neck cancer: a prospective study on patients treated with surgery or combined therapy with surgery and radiotherapy or radiochemotherapy.
    Veldhuis D; Probst G; Marek A; Noack V; Ural A; Adamietz I; Dazert S; Minovi A
    Eur Arch Otorhinolaryngol; 2016 Jan; 273(1):215-24. PubMed ID: 25575842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Geriatric screening tools are of limited value to predict decline in functional status and quality of life: results of a cohort study.
    Deckx L; van den Akker M; Daniels L; De Jonge ET; Bulens P; Tjan-Heijnen VC; van Abbema DL; Buntinx F
    BMC Fam Pract; 2015 Mar; 16():30. PubMed ID: 25888485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive Geriatric Assessment and quality of life after localized prostate cancer radiotherapy in elderly patients.
    Goineau A; Campion L; d'Aillières B; Vié B; Ghesquière A; Béra G; Jaffres D; de Laroche G; Magné N; Artignan X; Chamois J; Bergerot P; Martin E; Créhange G; Deniaud-Alexandre E; Buthaud X; Belkacémi Y; Doré M; de Decker L; Supiot S
    PLoS One; 2018; 13(4):e0194173. PubMed ID: 29630602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comprehensive geriatric assessment screening questionnaire (CGA-GOLD) for older people undergoing treatment for cancer.
    Whittle AK; Kalsi T; Babic-Illman G; Wang Y; Fields P; Ross PJ; Maisey NR; Hughes S; Kwan W; Harari D
    Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 27132979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying cutoff scores for the EORTC QLQ-C30 and the head and neck cancer-specific module EORTC QLQ-H&N35 representing unmet supportive care needs in patients with head and neck cancer.
    Jansen F; Snyder CF; Leemans CR; Verdonck-de Leeuw IM
    Head Neck; 2016 Apr; 38 Suppl 1():E1493-500. PubMed ID: 27111696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.